Showing results (1451-1460 of 1,897) with videos related to

Sort By:
Pageof 190
Pathophysiology : the Official Journal of the International Society for Pathophysiology|June 17, 2019
Cholesterol enriched diet suppresses ATF6 and PERK and upregulates the IRE1 pathways of the unfolded protein response in spontaneously hypertensive rats: Relevance to pathophysiology of atherosclerosis in the setting of hypertensionLesya V Tumanovska, R James Swanson, Zoya O Serebrovska, et al.
British Journal of Cancer|November 27, 2008
No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trialU Nur, B Rachet, M K B Parmar, et al.
Nature|September 8, 1994
Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11qL Hashimoto, C Habita, J P Beressi, et al.
Electrophoresis|September 1, 1992
Plasma protein map: an update by microsequencingG J Hughes, S Frutiger, N Paquet, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 20, 2007
Aggressive percutaneous mechanical thrombectomy of deep venous thrombosis: early clinical resultsFrank R Arko, Charles M Davis, Erin H Murphy, et al.
Pharmacology, Biochemistry, and Behavior|July 23, 2008
Acute nicotine reduces and repeated nicotine increases spontaneous activity in male and female Lewis ratsAdam J Prus, Robert E Vann, John A Rosecrans, et al.
Veterinary Surgery : VS|March 15, 2020
Assessment of the medium- to long-term radiographically confirmed outcome for juvenile dogs with hip dysplasia treated with double pelvic osteotomyPaul L Jenkins, Daniel R James, Joanna D White, et al.
American Journal of Human Genetics|July 1, 1992
Cloning of a candidate gene for ataxia-telangiectasia group DL N Kapp, R B Painter, L C Yu, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 12, 2025
Exercise and eating motivation in weight loss maintenance: revisiting the motivational spillover with the NoHoW studyAntónio L Palmeira, Eliana V Carraça, Inês Santos, et al.
Investigational New Drugs|May 14, 2013
A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinomaR C Turkington, C Purcell, C R James, et al.
Pageof 190